- Home
- BUSE vs ZLAB Comparison
BUSE vs ZLAB Comparison
Compare BUSE & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BUSE
- ZLAB
- Stock Information
- Founded
- BUSE 1868
- ZLAB 2013
- Country
- BUSE United States
- ZLAB China
- Employees
- BUSE N/A
- ZLAB N/A
- Industry
- BUSE Major Banks
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- BUSE Finance
- ZLAB Health Care
- Exchange
- BUSE Nasdaq
- ZLAB Nasdaq
- Market Cap
- BUSE 2.1B
- ZLAB 2.2B
- IPO Year
- BUSE N/A
- ZLAB 2017
- Fundamental
- Price
- BUSE $23.82
- ZLAB $19.99
- Analyst Decision
- BUSE Buy
- ZLAB Buy
- Analyst Count
- BUSE 7
- ZLAB 6
- Target Price
- BUSE $26.57
- ZLAB $57.22
- AVG Volume (30 Days)
- BUSE 369.2K
- ZLAB 1.0M
- Earning Date
- BUSE 10-28-2025
- ZLAB 11-06-2025
- Dividend Yield
- BUSE 4.21%
- ZLAB N/A
- EPS Growth
- BUSE N/A
- ZLAB N/A
- EPS
- BUSE 1.27
- ZLAB N/A
- Revenue
- BUSE $583,913,000.00
- ZLAB $441,629,000.00
- Revenue This Year
- BUSE $62.62
- ZLAB $40.71
- Revenue Next Year
- BUSE $11.33
- ZLAB $50.42
- P/E Ratio
- BUSE $18.76
- ZLAB N/A
- Revenue Growth
- BUSE 30.63
- ZLAB 24.14
- 52 Week Low
- BUSE $18.40
- ZLAB $19.51
- 52 Week High
- BUSE $27.50
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- BUSE 59.56
- ZLAB 19.41
- Support Level
- BUSE $22.12
- ZLAB $19.51
- Resistance Level
- BUSE $24.07
- ZLAB $20.29
- Average True Range (ATR)
- BUSE 0.54
- ZLAB 0.60
- MACD
- BUSE 0.15
- ZLAB 0.07
- Stochastic Oscillator
- BUSE 86.92
- ZLAB 15.22
About BUSE First Busey Corporation
First Busey Corporation is a financial holding company, whose subsidiaries provides retail and commercial banking services, remittance processing, and offers financial products and services with banking centers in Illinois, Missouri, Florida, and Indiana. The company's operations are managed through three operating segments consisting of Banking, FirsTech and Wealth Management. The banking segment generates a vast majority of its revenue.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.